N. Galie, M. Hoeper, M. Humbert, A. Torbicki, J. Vachiery et al., Guidelines for the diagnosis and treatment of pulmonary hypertension, Revista Portuguesa de Cardiologia (English Edition), vol.31, issue.1, pp.1219-63, 2009.
DOI : 10.1016/j.repce.2011.10.006

N. Galie, M. Hoeper, M. Humbert, A. Torbicki, J. Vachiery et al., Guidelines for the diagnosis and treatment of pulmonary hypertension, ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), pp.2493-537, 2009.
DOI : 10.1016/j.repce.2011.10.006

M. Humbert, O. Sitbon, and G. Simonneau, Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1461, 2004.
DOI : 10.1056/NEJMra040291
URL : https://hal.archives-ouvertes.fr/hal-01455600

B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais et al., Mutation, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.12, pp.1377-83, 2008.
DOI : 10.1164/rccm.200712-1807OC
URL : https://hal.archives-ouvertes.fr/inserm-00668454

E. Rosenzweig, J. Morse, J. Knowles, K. Chada, A. Khan et al., Clinical Implications of Determining BMPR2 Mutation Status in a Large Cohort of Children and Adults With Pulmonary Arterial Hypertension, The Journal of Heart and Lung Transplantation, vol.27, issue.6, pp.668-74, 2008.
DOI : 10.1016/j.healun.2008.02.009

B. Girerd, D. Montani, F. Coulet, B. Sztrymf, A. Yaici et al., Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation, Am J Respir Crit Care Med, issue.8, pp.181851-61, 2010.

R. Trembath, J. Thomson, R. Machado, N. Morgan, C. Atkinson et al., Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia, New England Journal of Medicine, vol.345, issue.5, pp.325-359, 2001.
DOI : 10.1056/NEJM200108023450503

R. Harrison, R. Berger, S. Haworth, R. Tulloh, C. Mache et al., Transforming Growth Factor-?? Receptor Mutations and Pulmonary Arterial Hypertension in Childhood, Circulation, vol.111, issue.4, pp.435-476, 2005.
DOI : 10.1161/01.CIR.0000153798.78540.87

A. Chaouat, F. Coulet, C. Favre, G. Simonneau, E. Weitzenblum et al., Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension, Thorax, vol.59, issue.5, pp.446-454, 2004.
DOI : 10.1136/thx.2003.11890

E. Austin, J. Phillips, J. Cogan, R. Hamid, C. Yu et al., Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension, Respiratory Research, vol.111, issue.23, p.87, 2009.
DOI : 10.1161/CIRCULATIONAHA.104.488486

M. Mcgoon, D. Gutterman, V. Steen, R. Barst, D. Mccrory et al., Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension, Chest, vol.126, issue.1, pp.14-34, 2004.
DOI : 10.1378/chest.126.1_suppl.14S

M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib et al., Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006.
DOI : 10.1164/rccm.200510-1668OC

O. Sitbon, M. Humbert, X. Jais, V. Ioos, A. Hamid et al., Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension, Circulation, vol.111, issue.23, pp.3105-3116, 2005.
DOI : 10.1161/CIRCULATIONAHA.104.488486

O. Sitbon, M. Humbert, H. Nunes, F. Parent, G. Garcia et al., Long-term intravenous epoprostenol infusion in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.40, issue.4, pp.780-788, 2002.
DOI : 10.1016/S0735-1097(02)02012-0

M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib et al., Survival in patients with idiopathic, familial, and anorexigenassociated pulmonary arterial hypertension in the modern management era, Am J Respir Crit Care Med, vol.181, p.4812, 2010.

J. West, J. Cogan, M. Geraci, L. Robinson, J. Newman et al., Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance, BMC Medical Genomics, vol.3, issue.3, p.45, 2008.
DOI : 10.1016/0960-7404(94)90047-7

E. Austin, J. Cogan, J. West, L. Hedges, R. Hamid et al., Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females, European Respiratory Journal, vol.34, issue.5, pp.1093-1102, 2009.
DOI : 10.1183/09031936.00010409

H. Kuzmiak and L. Maquat, Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges, Trends in Molecular Medicine, vol.12, issue.7, pp.306-322, 2006.
DOI : 10.1016/j.molmed.2006.05.005

L. Harries, C. Bingham, C. Bellanne-chantelot, A. Hattersley, and S. Ellard, The position of premature termination codons in the hepatocyte nuclear factor ???1 beta gene determines susceptibility to nonsense-mediated decay, Human Genetics, vol.18, issue.9, pp.214-238, 2005.
DOI : 10.1007/s00439-005-0023-y

R. Hamid, J. Cogan, L. Hedges, E. Austin, J. Phillips et al., allele, Human Mutation, vol.91, issue.4, pp.649-54, 2009.
DOI : 10.1002/humu.20922

N. Rudarakanchana, J. Flanagan, H. Chen, P. Upton, R. Machado et al., Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension, Human Molecular Genetics, vol.11, issue.13, pp.1517-1542, 2002.
DOI : 10.1093/hmg/11.13.1517

M. Nasim, A. Ghouri, B. Patel, V. James, N. Rudarakanchana et al., Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension, Human Molecular Genetics, vol.17, issue.11, pp.1683-94, 2008.
DOI : 10.1093/hmg/ddn059

. Girerd, Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension Respiratory Research, p.73, 2010.